Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol for Respiratory Muscle Strength in SCI
NCT02508311Phase 4Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2016
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in Respiratory muscle weakness, sponsored by VA Office of Research & Development. Started Jun 2016; status: terminated.
02
Drugs
salbutamol
03
Conditions
Respiratory muscle weakness
Beyond the preview
Go deeper on NCT02508311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508311.